4.2 Article

Clinical predictors of chimeric antigen receptor T-cell therapy neurotoxicity: a single-center study

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Clinical Correlates of Frontal Intermittent Rhythmic Delta Activity Without Structural Brain Lesion

Keun Tae Kim et al.

Summary: In this study, we investigated the clinical significance of FIRDA without structural brain lesions by reviewing 7689 EEGs. The majority of patients with FIRDA were found to have metabolic encephalopathy, with a smaller percentage attributed to neurodegenerative diseases, hypoxic encephalopathy, and infections.

CLINICAL EEG AND NEUROSCIENCE (2021)

Review Oncology

Side-effect management of chimeric antigen receptor (CAR) T-cell therapy

M-L Schubert et al.

Summary: CAR T-cell therapy targeting CD19-expressing B cells has shown promising results in treating refractory and/or relapsed B-cell malignancies, but also presents challenges such as cytokine release syndrome and neurotoxicity syndrome. Optimal management strategies for the side-effects associated with CAR T-cell therapy are crucial as it expands into other diseases in hematology and oncology.

ANNALS OF ONCOLOGY (2021)

Article Oncology

Immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes

Noa G. Holtzman et al.

Summary: A single-center analysis of ICANS after CAR-T therapy in R/R LBCL showed that about half of patients developed ICANS, with the majority being high grade. Elevated pre-infusion fibrinogen and lactate dehydrogenase were associated with ICANS, but neither the development nor treatment of ICANS were linked to inferior treatment outcomes. The novel finding of high fibrinogen level on day 0 can help identify patients at higher risk for ICANS.

NEURO-ONCOLOGY (2021)

Article Geriatrics & Gerontology

Does This Patient Have Parkinson Disease or Essential Tremor?

Stephen G. Reich

CLINICS IN GERIATRIC MEDICINE (2020)

Article Clinical Neurology

The Virtual Neurologic Exam: Instructional Videos and Guidance for the COVID-19 Era

Mariam Al Hussona et al.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2020)

Article Clinical Neurology

Clinical Predictors of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy

Daniel B. Rubin et al.

JAMA NEUROLOGY (2020)

Review Immunology

Cytokines in CAR T Cell-Associated Neurotoxicity

Juliane Gust et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Description of neurotoxicity in a series of patients treated with CAR T-cell therapy

Catherine Belin et al.

SCIENTIFIC REPORTS (2020)

Review Clinical Neurology

Neurotoxicity-CAR T-cell therapy: what the neurologist needs to know

Lorna Neill et al.

PRACTICAL NEUROLOGY (2020)

Article Oncology

CAR T-Cell Associated Neurotoxicity: Mechanisms, Clinicopathologic Correlates, and Future Directions

Bradley D. Hunter et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)

Article Oncology

Managing the toxicities of CAR T-cell therapy

Sattva S. Neelapu

HEMATOLOGICAL ONCOLOGY (2019)

Article Hematology

ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

Daniel W. Lee et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)

Article Medicine, General & Internal

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Stephen J. Schuster et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Review Oncology

Chimeric antigen receptor T-cell therapy - assessment and management of toxicities

Sattva S. Neelapu et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Article Medicine, General & Internal

Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas

Stephen J. Schuster et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

S. S. Neelapu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Clinical Neurology

Delirium in elderly adults: diagnosis, prevention and treatment

Tamara G. Fong et al.

NATURE REVIEWS NEUROLOGY (2009)

Article Critical Care Medicine

Intensive Care Delirium Screening Checklist: evaluation of a new screening tool

N Bergeron et al.

INTENSIVE CARE MEDICINE (2001)